Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Fagron Compounding Services recalls bevacizumab (Avastin) Injection

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Lack of Assurance of Sterility
Products
  • bevacizumab (Avastin) Injection
Where it was sold

USA nationwide.

Nationwide

Units affected
109,320 syringes
About this recall
bevacizumab (Avastin) Injection, 1.25mg/0.05mL (0.12 mL Fill), Sterile Single-Dose Syringe, Fagron Sterile Services, 8710 E 34th St N. Wichita, KS 67226